Form 4: Tonix Pharmaceuticals Director Richard H. Bagger Acquires Stock Options
SEC Form 4 Filing
Director Richard H. Bagger acquired stock options in Tonix Pharmaceuticals Holding Corp. on May 13, 2025.
Summary
- Richard H. Bagger, a director of Tonix Pharmaceuticals Holding Corp., reported a transaction involving stock options.
- On May 13, 2025, Bagger acquired 10,000 stock options with an exercise price of $20.18.
- These options vest on the earlier of the one-year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders and expire on May 13, 2035.
- Following the transaction, Bagger directly owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it indicates a director's belief in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of the stock option grant and transaction. |
| 05/13/2026 | Expiration date of the options if vesting occurs one year after the grant date. |
| 2026 Annual Meeting of Stockholders | Options vest on the earlier of the one-year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders. |
| 05/13/2035 | Expiration date of the stock options. |
| 05/15/2025 | Date of the Form 4 filing. |
Keywords
stock options, Form 4, TNXP, Tonix Pharmaceuticals, director, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.